Description
This product utilizes dendritic cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1S43D22-26). We employs the pAS (SV40-mCherry-IL-17-HindIII) vector components and the SynExpress system of the lncRNA Base Editing/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1S43D22-26
Species Reactivity
Human
Cell Source
Dendritic cells
Sensor Gene
mCherry
Promoter
SV40
Effector Gene
IL-17
Insertion Sites
HindIII
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
pAS
Transformation Accuracy
0.95
Cell Culture
3D Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.